New research from Precision Neuroscience shows its brain-computer interface can record high-resolution signals without invasive surgery.

UK pharma and healthcare stocks drive FTSE 100 to a record high, led by AstraZeneca, as trade policy shifts boost investor confidence.

Read this month’s pharma news roundup, featuring AI in healthcare risks, GLP-1 drug trials beyond obesity and Trump’s US tariffs.

England’s NHS is launching NHS Online, a fully digital hospital, to speed up specialist appointments, cut wait times and improve care access.

Donald Trump has threatened sweeping new trade measures on the pharma sector unless manufacturers commit to producing in the US.

Sanofi has committed $625m to its corporate venture capital arm, Sanofi Ventures, for funding biotech and digital health companies.

Pfizer is claiming a space in the global obesity market as it announces plans to acquire weight loss drug developer Metsera for $4.9bn.

Roche is acquiring US-based biotech 89bio in a deal worth up to $3.5 billion, bolstering its pipeline with a late-stage therapy for Metabolic Dysfunction-Associated Steatohepatitis (MASH).